BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 31359124)

  • 21. Diffusion-weighted magnetic resonance imaging in the characterization of axillary lymph nodes in patients with breast cancer.
    Fornasa F; Nesoti MV; Bovo C; Bonavina MG
    J Magn Reson Imaging; 2012 Oct; 36(4):858-64. PubMed ID: 22648570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apparent diffusion coefficient value in invasive ductal carcinoma at 3.0 Tesla: is it correlated with prognostic factors?
    Guvenc I; Akay S; Ince S; Yildiz R; Kilbas Z; Oysul FG; Tasar M
    Br J Radiol; 2016; 89(1060):20150614. PubMed ID: 26853508
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apparent diffusion coefficient cannot predict molecular subtype and lymph node metastases in invasive breast cancer: a multicenter analysis.
    Surov A; Chang YW; Li L; Martincich L; Partridge SC; Kim JY; Wienke A
    BMC Cancer; 2019 Nov; 19(1):1043. PubMed ID: 31690273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diffusion-weighted MR imaging increases diagnostic accuracy of breast MR imaging for predicting axillary metastases in breast cancer patients.
    Guvenc I; Whitman GJ; Liu P; Yalniz C; Ma J; Dogan BE
    Breast J; 2019 Jan; 25(1):47-55. PubMed ID: 30444286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Invasive ductal carcinoma: correlation of apparent diffusion coefficient value with pathological prognostic factors.
    Razek AA; Gaballa G; Denewer A; Nada N
    NMR Biomed; 2010 Jul; 23(6):619-23. PubMed ID: 20232453
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peritumoral apparent diffusion coefficients for prediction of lymphovascular invasion in clinically node-negative invasive breast cancer.
    Mori N; Mugikura S; Takasawa C; Miyashita M; Shimauchi A; Ota H; Ishida T; kasajima A; Takase K; Kodama T; Takahashi S
    Eur Radiol; 2016 Feb; 26(2):331-9. PubMed ID: 26024846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can Diffusion-Weighted Imaging and Related Apparent Diffusion Coefficient be a Prognostic Value in Women With Breast Cancer?
    Rabasco P; Caivano R; Simeon V; Dinardo G; Lotumolo A; Gioioso M; Villonio A; Iannelli G; D'Antuono F; Zandolino A; Macarini L; Guglielmi G; Cammarota A
    Cancer Invest; 2017 Feb; 35(2):92-99. PubMed ID: 28107084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is there any relationship between adc values of diffusion-weighted imaging and the histopathological prognostic factors of invasive ductal carcinoma?
    Aydin H; Guner B; Esen Bostanci I; Bulut ZM; Aribas BK; Dogan L; Gulcelik MA
    Br J Radiol; 2018 Apr; 91(1084):20170705. PubMed ID: 29299933
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diffusion-weighted imaging of breast lesions: Region-of-interest placement and different ADC parameters influence apparent diffusion coefficient values.
    Bickel H; Pinker K; Polanec S; Magometschnigg H; Wengert G; Spick C; Bogner W; Bago-Horvath Z; Helbich TH; Baltzer P
    Eur Radiol; 2017 May; 27(5):1883-1892. PubMed ID: 27578047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of peritumoral region features assessed on breast MRI and prognosis of breast cancer: a systematic review and meta-analysis.
    Zhao S; Li Y; Ning N; Liang H; Wu Y; Wu Q; Wang Z; Tian J; Yang J; Gao X; Liu A; Song Q; Zhang L
    Eur Radiol; 2024 Feb; ():. PubMed ID: 38334760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic value of diffusion-weighted magnetic resonance imaging: differentiation of benign and malignant lymph nodes in different regions of the body.
    Seber T; Caglar E; Uylar T; Karaman N; Aktas E; Aribas BK
    Clin Imaging; 2015; 39(5):856-62. PubMed ID: 26091745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diffusion-weighted imaging (DWI) with apparent diffusion coefficient (ADC) mapping as a quantitative imaging biomarker for prediction of immunohistochemical receptor status, proliferation rate, and molecular subtypes of breast cancer.
    Horvat JV; Bernard-Davila B; Helbich TH; Zhang M; Morris EA; Thakur SB; Ochoa-Albiztegui RE; Leithner D; Marino MA; Baltzer PA; Clauser P; Kapetas P; Bago-Horvath Z; Pinker K
    J Magn Reson Imaging; 2019 Sep; 50(3):836-846. PubMed ID: 30811717
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diffusion-weighted MRI: impact of the size of the ROI in detecting metastases in subcentimeter lymph nodes in head and neck squamous cell carcinoma.
    Jović A; Fila J; Gršić K; Ivkić M; Ozretić D
    Neuroradiology; 2020 Aug; 62(8):987-994. PubMed ID: 32418025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Added Value of MRI for Invasive Breast Cancer including the Entire Axilla for Evaluation of High-Level or Advanced Axillary Lymph Node Metastasis in the Post-ACOSOG Z0011 Trial Era.
    Byon JH; Park YV; Yoon JH; Moon HJ; Kim EK; Kim MJ; You JK
    Radiology; 2021 Jul; 300(1):46-54. PubMed ID: 33904772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic value of breast MRI for predicting metastatic axillary lymph nodes in breast cancer patients: diffusion-weighted MRI and conventional MRI.
    Kim EJ; Kim SH; Kang BJ; Choi BG; Song BJ; Choi JJ
    Magn Reson Imaging; 2014 Dec; 32(10):1230-6. PubMed ID: 25072504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation of the SUVmax of FDG-PET and ADC values of diffusion-weighted MR imaging with pathologic prognostic factors in breast carcinoma.
    Kitajima K; Yamano T; Fukushima K; Miyoshi Y; Hirota S; Kawanaka Y; Miya M; Doi H; Yamakado K; Hirota S
    Eur J Radiol; 2016 May; 85(5):943-9. PubMed ID: 27130054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discrimination of axillary metastatic from nonmetastatic lymph nodes with PROPELLER diffusion-weighted MR imaging in a metastatic breast cancer model and its correlation with cellularity.
    Junping W; Tongguo S; Yunting Z; Chunshui Y; Renju B
    J Magn Reson Imaging; 2012 Sep; 36(3):624-31. PubMed ID: 22570219
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of axillary lymph node metastasis with diffusion-weighted MR imaging.
    Iima M; Kataoka M; Okumura R; Togashi K
    Clin Imaging; 2014; 38(5):633-6. PubMed ID: 24908365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced Field-of-View Diffusion-Weighted Imaging in Histological Characterization of Rectal Cancer: Impact of Different Region-of-Interest Positioning Protocols on Apparent Diffusion Coefficient Measurements.
    Peng Y; Xu C; Hu X; Shen Y; Hu D; Kamel I; Li Z
    Eur J Radiol; 2020 Jun; 127():109028. PubMed ID: 32361587
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of axillary node metastasis using diffusion-weighted MRI in breast cancer.
    Kamitani T; Hatakenaka M; Yabuuchi H; Matsuo Y; Fujita N; Jinnouchi M; Nagao M; Shirahane K; Tokunaga E; Honda H
    Clin Imaging; 2013; 37(1):56-61. PubMed ID: 23206608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.